Viridian Therapeutics, Inc.\DE (VRDN) Times Interest Earned (2016 - 2025)
Viridian Therapeutics, Inc.\DE (VRDN) has 12 years of Times Interest Earned data on record, last reported at -$37.4 in Q4 2025.
- For Q4 2025, Times Interest Earned rose 99.62% year-over-year to -$37.4; the TTM value through Dec 2025 reached -$73.44, up 57.71%, while the annual FY2025 figure was -$73.44, 46.04% up from the prior year.
- Times Interest Earned reached -$37.4 in Q4 2025 per VRDN's latest filing, up from -$70.69 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$37.4 in Q4 2025 and bottomed at -$9719.1 in Q4 2024.
- Average Times Interest Earned over 5 years is -$1374.3, with a median of -$180.16 recorded in 2022.
- Peak YoY movement for Times Interest Earned: tumbled 5338.94% in 2024, then skyrocketed 99.62% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$9693.7 in 2021, then skyrocketed by 96.99% to -$292.06 in 2022, then soared by 38.82% to -$178.7 in 2023, then crashed by 5338.94% to -$9719.1 in 2024, then skyrocketed by 99.62% to -$37.4 in 2025.
- Per Business Quant database, its latest 3 readings for Times Interest Earned were -$37.4 in Q4 2025, -$70.69 in Q3 2025, and -$207.72 in Q2 2025.